Oxytocin ergometrine
PreclinicalSmall molecule
Oxytocin ergometrine is one of 5 small molecule programs targeting Caesarean Section. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
4 competitors in Caesarean Section
#DrugCompanyPhaseTrials
1Intrathecal Morphine
Pacira Pharmaceuticals, IncPhase 3
Chirocaine
PPurdue Pharma LP
Preclinical
Intrathecal Fentanyl
MMansoura University
Preclinical
Bupivacaine-Fentanyl
SSamuel Lunenfeld Research Institute, Mount Sinai Hospital
Preclinical
Oxytocin ergometrine
UUniversity of Pretoria
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Oxytocin ergometrine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Pretoria